§331 Prohibited acts

section 2223 of this title, referred to in par. (e), was in the original “section 204 of the FDA Food Safety Modernization Act”, meaning section 204 of Pub. L. 111–353, which enacted section 2223 of this title and amended this section and section 381 of this title. section 353c of this title, referred to in par. (kk), was in the original a reference to section 503B of act June 25, 1938, and was translated as if it referred to section 503C of that Act, to reflect the probable intent of Congress and the renumbering of section 503B as 503C by Pub. L. 113–54, title I, § 102(a)(1), Nov. 27, 2013, 127 Stat. 587, and its transfer to section 353c of this title. A new section 503B, which was enacted by section 102(a)(2) of Pub. L. 113–54, is classified to section 353b of this title and does not relate to television advertisements.

2022—Subsec. (d). Pub. L. 117–328, § 3503(a)(1)(B), which directed the substitution of “, 360bbb–3, or 364c” for “or 360bbb–3” in par. (d), was executed by making the substitution in subsec. (d) to reflect the probable intent of Congress. Subsec. (e). Pub. L. 117–328, § 3503(a)(4)(A), substituted “360bbb–3, 364a, 373” for “360bbb–3, 373” and “360bbb–3, 364a, 364g, 379aa” for “360bbb–3, 379aa”. Subsec. (q)(3). Pub. L. 117–328, § 3305(b), added par. (3). Subsec. (ii). Pub. L. 117–328, § 3503(a)(4)(B)(ii), inserted “or required under section 364a(a) of this title” after “report (as defined under section 379aa or 379aa–1 of this title”. Pub. L. 117–328, § 3503(a)(4)(B)(i), substituted “364, 379aa, or 379aa–1 of this title) or” for “379aa or 379aa–1 of this title) or”. Subsec. (fff). Pub. L. 117–328, § 2513(a), added subsec. (fff). Subsec. (ggg). Pub. L. 117–328, § 3210(c), added subsec. (ggg). Subsecs. (hhh), (iii). Pub. L. 117–328, § 3503(a)(1)(A), added subsecs. (hhh) and (iii). 2018—Par. (cc). Pub. L. 115–271, § 3022(b)(1), inserted “or a drug” after “food” and “from such activity” after “person debarred”. Par. (eee). Pub. L. 115–271, § 3012(a), added par. (eee). 2016—Subsec. (r). Pub. L. 114–255 inserted “, drug,” after “device” in two places. 2015—Par. (ddd). Pub. L. 114–114 added par. (ddd). 2013—Par. (t). Pub. L. 113–54, § 206(a), struck out “or” after “the requirements of section 353(d) of this title,” and inserted “, failure to comply with the requirements under section 360eee–1 of this title, the failure to comply with the requirements under section 360eee–3 of this title, as applicable,” after “in violation of section 353(e) of this title”. Par. (ccc). Pub. L. 113–54, § 103(a), added par. (ccc). 2012—Par. (aaa). Pub. L. 112–144, § 714(a), added par. (aaa). Par. (bbb). Pub. L. 112–144, § 715(a), added par. (bbb). 2011—Par. (d). Pub. L. 111–353, § 102(d)(1), inserted “350d,” after “344,”. Par. (e). Pub. L. 111–353, §§ 204(j)(1), 211(c), substituted “350f(j)” for “350f(g)” and inserted before period at end “; or the violation of any recordkeeping requirement under section 2223 of this title (except when such violation is committed by a farm)”. Par. (uu). Pub. L. 111–353, § 103(e), added par. (uu). Par. (vv). Pub. L. 111–353, § 105(c), added par. (vv). Par. (ww). Pub. L. 111–353, § 106(d), added par. (ww). Par. (xx). Pub. L. 111–353, § 206(d), added par. (xx). Par. (yy). Pub. L. 111–353, § 211(b), added par. (yy). Par. (zz). Pub. L. 111–353, § 301(b), added par. (zz). 2009—Pars. (a) to (c). Pub. L. 111–31, § 103(b)(1)–(3), inserted “tobacco product,” after “device,”. Par. (e). Pub. L. 111–31, § 103(b)(4)(B), which directed substitution of “379aa–1, 387i, or 387t of this title or the refusal to permit access to” for “or 379aa–1 of this title or the refusal to permit access to”, was executed by making the substitution for “or 379aa–1 of this title, or the refusal to permit access to”, to reflect the probable intent of Congress. Pub. L. 111–31, § 103(b)(4)(A), struck out period after “360ccc–1(i)”. Pars. (g), (h). Pub. L. 111–31, § 103(b)(5), (6), inserted “tobacco product,” after “device,”. Par. (j). Pub. L. 111–31, § 103(b)(7), struck out period after “360ccc–2” and substituted “379, 379e, 387d, 387e, 387f, 387g, 387h, 387i, or 387t(b)” for “379, or 379e”. Par. (k). Pub. L. 111–31, § 103(b)(8), inserted “tobacco product,” after “device,”. Par. (p). Pub. L. 111–31, § 103(b)(9), added par. (p) and struck out former par. (p) which read as follows: “The failure to register in accordance with section 360 of this title, the failure to provide any information required by section 360(j) or 360(k) of this title, or the failure to provide a notice required by section 360(j)(2) of this title.” Par. (q)(1). Pub. L. 111–31, § 103(b)(10), added subpar. (1) and struck out former subpar. (1) which read as follows: “The failure or refusal to (A) comply with any requirement prescribed under section 360h or 360j(g) of this title, (B) furnish any notification or other material or information required by or under section 360i or 360j(g) of this title, or (C) comply with a requirement under section 360l of this title.” Par. (q)(2). Pub. L. 111–31, § 103(b)(11), substituted “device or tobacco product,” for “device,”. Par. (r). Pub. L. 111–31, § 103(b)(12), inserted “or tobacco product” after “device” in two places. Pars. (oo) to (tt). Pub. L. 111–31, § 103(b)(13), added pars. (oo) to (tt). 2007—Par. (e). Pub. L. 110–85, § 1005(d)(1), substituted “350c, 350f(g),” for “350c,” and “350c(b), 350f” for “350c(b)”. Par. (jj). Pub. L. 110–85, § 801(b)(1), added par. (jj). Par. (kk). Pub. L. 110–85, § 901(d)(1), added par. (kk). Par. (ll). Pub. L. 110–85, § 912(a), added par. (ll). Pars. (mm), (nn). Pub. L. 110–85, § 1005(d)(2), added pars. (mm) and (nn). 2006—Par. (e). Pub. L. 109–462, § 3(b), substituted “374(a), 379aa, or 379aa–1” for “374(a), or 379aa” and “360bbb–3, 379aa, or 379aa–1” for “360bbb–3, or 379aa”. Pub. L. 109–462, § 2(c), substituted “, 374(a), or 379aa” for “, or 374(a)” and “, 360bbb–3, or 379aa” for “, or 360bbb–3”. Par. (ii). Pub. L. 109–462, § 4(a), added par. (ii). 2005—Par. (e). Pub. L. 109–59, § 7202(d), inserted “350e,” before “354,” in two places. Par. (hh). Pub. L. 109–59, § 7202(e), added par. (hh). 2004—Par. (e). Pub. L. 108–282, § 102(b)(5)(C), which directed the substitution of “360b(a)(4)(C), 360b (j), (l) or (m), 360ccc–1(i).” for “360b(a)(4)(C), 360b(j), (l) or (m)” was executed by making the substitution for “360b(a)(4)(C), 360b(j), (l), or (m)”, to reflect the probable intent of Congress. Par. (j). Pub. L. 108–282, § 102(b)(5)(D), substituted “360j, 360ccc, 360ccc–1, 360ccc–2.” for “360j”. Par. (gg). Pub. L. 108–214 amended par. (gg) generally. Prior to amendment, text read as follows: “The knowing failure of a person accredited under paragraph (2) of section 374(g) of this title to comply with paragraph (7)(E) of such section; the knowing inclusion by such a person of false information in an inspection report under paragraph (7)(A) of such section; or the knowing failure of such a person to include material facts in such a report.” 2003—Par. (d). Pub. L. 108–136 substituted “section 344, 355, or 360bbb–3” for “section 344 or 355”. Par. (e). Pub. L. 108–136 inserted “360bbb–3,” after “350c, 354,” and substituted “360i, or 360bbb–3” for “or 360i”. Par. (aa). Pub. L. 108–173 substituted “prescription drug in violation of section 384” for “covered product in violation of section 384”. 2002—Par. (e). Pub. L. 107–188, § 306(c)(1), substituted “by section 350a, 350c, 354, 373, or 374(a) of this title” for “by section 350a, 354, or 373 of this title” and “under section 350a, 350c(b)” for “under section 350a”. Par. (j). Pub. L. 107–188, § 306(c)(2), inserted “350c,” after “350a,”. Par. (w). Pub. L. 107–188, § 322(b), amended par. (w) generally. Prior to amendment, par. (w) read as follows: “The making of a knowingly false statement in any record or report required or requested under subparagraph (A) or (B) of section 381(d)(3) of this title, the failure to submit or maintain records as required by section 381(d)(3)(A) and 381(d)(3)(B) of this title, the release into interstate commerce of any article imported into the United States under section 381(d)(3) of this title or any finished product made from such article (except for export in accordance with section 381(e) or 382 of this title or section 262(h) of title 42), or the failure to export or destroy any component, part or accessory not incorporated into a drug, biological product or device that will be exported in accordance with section 381(e) or 382 of this title or section 262(h) of title 42.” Par. (bb). Pub. L. 107–188, § 303(b), added par. (bb). Par. (cc). Pub. L. 107–188, § 304(d), added par. (cc). Par. (dd). Pub. L. 107–188, § 305(b), added par. (dd). Par. (ee). Pub. L. 107–188, § 307(b), added par. (ee). Par. (ff). Pub. L. 107–188, § 321(b)(2), added par. (ff). Par. (gg). Pub. L. 107–250 added par. (gg). 2000—Par. (aa). Pub. L. 106–387 added par. (aa). 1997—Par. (e). Pub. L. 105–115, § 125(b)(2)(B), struck out “357(d) or (g),” after “355(i) or (k),”. Par. (i)(1). Pub. L. 105–115, § 125(a)(2)(C), struck out “, 356, 357,” before “or 379e of this title”. Par. (j). Pub. L. 105–115, § 125(a)(2)(A), struck out “356, 357,” before “360,”. Par. (l). Pub. L. 105–115, § 421, struck out par. (l) which read as follows: “The using, on the labeling of any drug or device or in any advertising relating to such drug or device, of any representation or suggestion that approval of an application with respect to such drug or device is in effect under section 355, 360e, or 360j(g) of this title, as the case may be, or that such drug or device complies with the provisions of such section.” Par. (x). Pub. L. 105–115, § 204(b), added par. (x). Par. (y). Pub. L. 105–115, § 210(c), added par. (y). Par. (z). Pub. L. 105–115, § 401(b), temporarily added par. (z) which related to dissemination of information in violation of section 360aaa of this title. See Effective and Termination Dates of 1997 Amendment note below. 1996—Par. (e). Pub. L. 104–250 inserted “, 354,” before “or 373 of this title” and “354,” before “355(i) or (k)”. Par. (j). Pub. L. 104–170 inserted before period at end of first sentence “; or the violating of section 346a(i)(2) of this title or any regulation issued under that section.” Pars. (u) to (w). Pub. L. 104–134 redesignated par. (u) relating to introduction into interstate commerce of unsafe dietary supplement as (v) and added par. (w). 1994—Par. (e). Pub. L. 103–396, § 2(b)(1)(A), substituted “357(d) or (g), 360b(a)(4)(C),” for “357(d) or (g),”. Par. (u). Pub. L. 103–417 added par. (u) relating to introduction into interstate commerce of unsafe dietary supplement. Pub. L. 103–396, § 2(b)(1)(B), added par. (u) relating to failure to comply with

of 2022 Amendment Pub. L. 117–328, div. FF, title III, § 3305(d), Dec. 29, 2022, 136 Stat. 5833, provided that: “The

made by subsections (a) and (b) [enacting section 360n–2 of this title and amending this section] shall take effect 90 days after the date of enactment of this Act [Dec. 29, 2022]. An application or submission submitted before such

shall not be subject to the requirements under subsection (a) or (b) of section 524B of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360n–2(a), (b)], as added by this section.” Pub. L. 117–328, div. FF, title III, § 3503(b)(1), Dec. 29, 2022, 136 Stat. 5859, provided that: “The

made by subsection (a) [amending this section and section 361, 362, and 381 of this title] shall take effect on the date that is 1 year after the date of enactment of this Act [Dec. 29, 2022].”

of 2018 Amendment Pub. L. 115–271, title III, § 3012(d), Oct. 24, 2018, 132 Stat. 3936, provided that: “section 301(eee) [21 U.S.C. 331(eee)] and 569D [21 U.S.C. 360bbb–8d] of the Federal Food, Drug, and Cosmetic Act, as added by subsections (a) and (b), shall be effective beginning on the date of enactment of this Act [Oct. 24, 2018].”

of 2011 AmendmentAmendment by section 103(e) of Pub. L. 111–353 effective 18 months after Jan. 4, 2011, and applicable to a small business (as defined in the

promulgated under section 350g(n) of this title) beginning on the date that is 6 months after the

of such

and to a very small business (as defined in such

) beginning on the date that is 18 months after the

of such

, see section 103(i) of Pub. L. 111–353, set out as an

note under section 350g of this title. Pub. L. 111–353, title III, § 301(d), Jan. 4, 2011, 124 Stat. 3955, provided that: “The

made by this section [enacting section 384a of this title and amending this section and section 381 of this title] shall take effect 2 years after the date of enactment of this Act [Jan. 4, 2011].”

of 2007 Amendment Pub. L. 110–85, title IX, § 909, Sept. 27, 2007, 121 Stat. 950, provided that: “(a)

.—This subtitle [subtitle A (§§ 901–909) of title IX of Pub. L. 110–85, enacting section 353b and 355–1 of this title, amending this section, section 333, 352, and 355 of this title, and section 262 of Title 42, The Public Health and Welfare, and enacting provisions set out as notes under section 352, 355, and 355a of this title] takes effect 180 days after the date of the enactment of this Act [Sept. 27, 2007]. “(b) Drugs Deemed to Have Risk Evaluation and Mitigation Strategies.—“(1) In general.—A drug that was approved before the

of this Act [probably means “this subtitle”, see above] is, in accordance with paragraph (2), deemed to have in effect an approved risk evaluation and mitigation strategy under section 505–1 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355–1] (as added by section 901) (referred to in this section as the ‘Act’) if there are in effect on the

of this Act elements to assure safe use—“(A) required under section 314.520 or section 601.42 of title 21, Code of Federal

or “(B) otherwise agreed to by the applicant and the Secretary for such drug. “(2) Elements of strategy;

.—The approved risk evaluation and mitigation strategy in effect for a drug under paragraph (1)—“(A) is deemed to consist of the timetable required under section 505–1(d) and any additional elements under subsections (e) and (f) of such section in effect for such drug on the

of this Act; and “(B) is subject to

by the Secretary to the same extent as any other risk evaluation and mitigation strategy under section 505–1 of the Act, except that section 303(f)(4) and 502(y) and (z) of the Act [21 U.S.C. 333(f)(4), 352(y), (z)] (as added by section 902) shall not apply to such strategy before the Secretary has completed review of, and acted on, the first assessment of such strategy under such section 505–1. “(3) Submission.—Not later than 180 days after the

of this Act, the holder of an approved application for which a risk evaluation and mitigation strategy is deemed to be in effect under paragraph (1) shall submit to the Secretary a proposed risk evaluation and mitigation strategy. Such proposed strategy is subject to section 505–1 of the Act as if included in such application at the time of submission of the application to the Secretary.”

of 2006 AmendmentAmendment by section 2(c) of Pub. L. 109–462 effective 1 year after Dec. 22, 2006, see section 2(e)(1) of Pub. L. 109–462, set out as a note under section 352 of this title. Amendment by section 3(b) of Pub. L. 109–462 effective 1 year after Dec. 22, 2006, see section 3(d)(1) of Pub. L. 109–462, set out as a note under section 343 of this title. Pub. L. 109–462, § 4(b), Dec. 22, 2006, 120 Stat. 3475, provided that: “The amendment made by this section [amending this section] shall take effect 1 year after the date of enactment of this Act [Dec. 22, 2006].”

of 2005 Amendment Pub. L. 109–59, title VII, § 7204, Aug. 10, 2005, 119 Stat. 1914, provided that: “This subtitle [subtitle B (§§ 7201–7204) of title VII of Pub. L. 109–59, enacting section 350e of this title, amending this section, section 342 and 373 of this title, and section 5701 of Title 49, Transportation, omitting sections 5702 to 5714 of Title 49, and enacting provisions set out as a note under section 301 of this title] takes effect on October 1, 2005.”

of 2002 Amendment Pub. L. 107–188, title III, § 321(c), June 12, 2002, 116 Stat. 676, provided that: “The

made by this section [amending this section and section 381 of this title] take effect upon the expiration of the 90-day period beginning on the date of the enactment of this Act [June 12, 2002].” Effective and Termination Dates of 1997 AmendmentAmendment by section 204, 210, and 421 of Pub. L. 105–115 effective 90 days after Nov. 21, 1997, except as otherwise provided, see section 501 of Pub. L. 105–115, set out as a note under section 321 of this title. Amendment by section 401(b) of Pub. L. 105–115 effective 1 year after Nov. 21, 1997, or upon Secretary’s issuance of final

pursuant to section 401(c) of Pub. L. 105–115, whichever is sooner, and ceases to be effective Sept. 30, 2006, see section 401(d), (e) of Pub. L. 105–115, set out as an Effective and Termination Dates note under former section 360aaa of this title.

of 1994 AmendmentAmendment by Pub. L. 103–396 effective upon adoption of final

under section 2(c) of Pub. L. 103–396, set out as a

note under section 360b of this title, see section 2(d) of Pub. L. 103–396, set out as a note under section 360b of this title.

of 1990 Amendment Pub. L. 101–508, title IV, § 4755(c)(2), Nov. 5, 1990, 104 Stat. 1388–210, provided that the amendment made by section 4755(c)(2) is effective as if included in subtitle D of title VI of the Omnibus Budget Reconciliation Act of 1989, Pub. L. 101–239, title VI, §§ 6601, 6602, Dec. 19, 1989, 103 Stat. 2285, see 42 U.S.C. 300aa–1 note, 300aa–10 note.

of 1988 AmendmentAmendment by Pub. L. 100–293 effective upon expiration of 90 days after Apr. 22, 1988, see section 8(a) of Pub. L. 100–293, set out as a note under section 353 of this title.

of 1972 AmendmentAmendment by Pub. L. 92–387 effective on first day of sixth month beginning after Aug. 16, 1972, see section 5 of Pub. L. 92–387, set out as a note under section 360 of this title.

of 1970 AmendmentAmendment by Pub. L. 91–513 effective on first day of seventh calendar month that begins after Oct. 26, 1970, see section 704 of Pub. L. 91–513, set out as an

note under section 801 of this title.

of 1968

Amendment by Pub. L. 90–399 effective on first day of thirteenth calendar month after July 13, 1968, see section 108(a) of Pub. L. 90–399, set out as an

and Transitional Provisions note under section 360b of this title. Amendment by Pub. L. 90–639 applicable only with respect to violations of this chapter committed after Oct. 24, 1968, see section 6 of Pub. L. 90–639, set out as an

of 1968

Transitional Provisions note under section 321 of this title.

of 1965 AmendmentAmendment by Pub. L. 89–74 effective Feb. 1, 1966, see section 11 of Pub. L. 89–74, set out as a note under section 321 of this title.

of 1962 AmendmentAmendment by section 103(c) and 106(c) of Pub. L. 87–781 effective on first day of seventh calendar month following Oct. 1962, and amendment by section 104(e)(1) of Pub. L. 87–781 effective Oct. 10, 1962, see section 107 of Pub. L. 87–781, set out as a note under section 321 of this title. Pub. L. 87–781, title I, § 114(b), Oct. 10, 1962, 76 Stat. 791, provided that: “This section [amending this section] shall take effect on the first day of the seventh calendar month following the month in which this Act is enacted [October 1962].”

of 1960 AmendmentAmendment by Pub. L. 86–618 effective July 12, 1960, subject to provisions of section 203 of Pub. L. 86–618, see section 202 of Pub. L. 86–618, set out as a note under section 379e of this title.

of 1958 AmendmentAmendment by Pub. L. 85–929 effective Sept. 6, 1958, see section 6(a) of Pub. L. 85–929, set out as a note under section 342 of this title.

of 1950 AmendmentAmendment by act Mar. 16, 1950, effective July 1, 1950, see section 7 of that act, set out as an

note under section 347 of this title.

Pub. L. 113–54, title I, § 104, Nov. 27, 2013, 127 Stat. 597, provided that: “In promulgating any

to implement this title [enacting subpart 9 of part C of subchapter VII of this chapter and section 353a–1 and 353b of this title, amending this section and section 352, 353a, 352b, and 353c of this title, and enacting provisions set out as notes under section 301 of this title] (and the

made by this title), the Secretary of Health and Human Services shall— “(1) issue a notice of proposed rulemaking that includes the proposed regulation; “(2) provide a period of not less than 60 calendar days for comments on the proposed regulation; and “(3) publish the final regulation not more than 18 months following publication of the proposed rule and not less than 30 calendar days before the

of such final regulation.” Secretary of Health and Human Services to promulgate

to implement

made by section 401 of Pub. L. 105–115 not later than 1 year after Nov. 21, 1997, see section 401(c) of Pub. L. 105–115, set out as a note under section 360aaa of this title.

s Pub. L. 113–54, title II, § 208, Nov. 27, 2013, 127 Stat. 640, provided that: “Except as provided in the

made by paragraphs (1), (2), and (3) of section 204(a) [amending section 353 of this title] and by section 206(a) [amending this section], nothing in this title [enacting part H of subchapter V of this chapter, amending this section and section 333, 352, 353, and 360eee–1 of this title, and enacting provisions set out as notes under section 301, 333, and 353 of this title] (including the

made by this title) shall be construed as altering any authority of the Secretary of Health and Human Services with respect to a drug subject to section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)(1)) under any other provision of such Act [21 U.S.C. 301 et seq.] or the Public Health Service Act (42 U.S.C. 201 et seq.).” Amendment by Pub. L. 91–513 not to affect or abate any prosecutions for violation of law or any civil seizures or forfeitures and injunctive proceedings commenced prior to the

of such amendment, and all administrative proceedings pending before the Bureau of Narcotics and Dangerous Drugs [now the Drug

Administration] on Oct. 27, 1970, to be continued and brought to final determination in accord with laws and

in effect prior to Oct. 27, 1970, see section 702 of Pub. L. 91–513, set out as a note under section 321 of this title.

of 2022 AmendmentNothing in amendment made by section 3210(c) of Pub. L. 117–328 to be construed to affect ongoing withdrawal proceedings for products approved pursuant to section 356(c) of this title for which a notice of proposed withdrawal has been published in the Federal Register prior to Dec. 29, 2022, see section 3210(f) of Pub. L. 117–328, set out as a note under section 356 of this title. Pub. L. 117–328, div. FF, title III, § 3305(c), Dec. 29, 2022, 136 Stat. 5833, provided that: “Nothing in this section [enacting section 360n–2 of this title, amending this section, and enacting provisions set out as notes under this section and section 360n–2 of this title], including the

made by this section, shall be construed to affect the Secretary’s [of Health and Human Services] authority related to ensuring that there is a reasonable assurance of the safety and effectiveness of devices, which may include ensuring that there is a reasonable assurance of the cybersecurity of certain cyber devices, including for devices approved or cleared prior to the date of enactment of this Act [Dec. 29, 2022].” [For definition of “device” as used in section 3305(c) of Pub. L. 117–328, set out above, see section 321(h) of this title, as made applicable by section 3305(h) of Pub. L. 117–328, which is set out as a note under section 360n–2 of this title.] Nothing in amendment made by section 3503(a)(1), (4)(A), (B) of Pub. L. 117–328, to be construed to authorize the disclosure of information that is prohibited from disclosure under section 331(j) of this title or section 1905 of title 18 or that is subject to withholding under section 552(b)(4) of title 5, see section 3503(c)(2) of Pub. L. 117–328, set out as a

Confidentiality note under section 364 of this title.

of 2015 Amendment Pub. L. 114–114, § 2(d), Dec. 28, 2015, 129 Stat. 3130, provided that: “Nothing in this Act [amending this section and enacting provisions set out as notes under this section and section 301 of this title] (or the

made by this Act) shall be construed to apply with respect to drugs that are not also cosmetics (as such terms are defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)).”

of 2011 AmendmentNothing in

by section 103(e), 105(c), 106(d), 204(j)(1), 211(b), (c), and 301(b) of Pub. L. 111–353 to be construed to apply to certain alcohol-related facilities, see section 2206 of this title. Nothing in

by Pub. L. 111–353 to be construed to alter jurisdiction and authorities established under certain other Acts or in a manner inconsistent with international agreements to which the United States is a party, see section 2251 and 2252 of this title.

of 2009

Pub. L. 111–31, div. A, title I, § 103(p), June 22, 2009, 123 Stat. 1838, provided that: “Nothing in this section [amending this section and section 333, 334, 355, 360m, 372 to 374, 375, 379a, 381, 393, 399, and 679 of this title and enacting provisions set out as notes under section 333 and 387c of this title] is intended or shall be construed to expand, contract, or otherwise modify or amend the existing limitations on State government authority over tribal restricted fee or trust lands.”

of 2002

Pub. L. 107–188, title III, § 315, June 12, 2002, 116 Stat. 675, provided that: “Nothing in this title [enacting section 350c, 350d, 398, 399, and 679c of this title, section 3353, 3354, 8319, and 8320 of Title 7, Agriculture, and section 247b–20 of Title 42, The Public Health and Welfare, amending this section, section 334, 335a, 342, 343, 360, 372, 374, and 381 of this title, and section 43 of Title 18, Crimes and Criminal Procedure, and enacting provisions set out as notes under this section and section 341, 350c, 350d, and 381 of this title], or an amendment made by this title, shall be construed to alter the jurisdiction between the Secretaries of Agriculture and of Health and Human Services, under applicable statutes and

.” Preemption of State Laws Pub. L. 114–114, § 2(c), Dec. 28, 2015, 129 Stat. 3129, provided that: “No State or political subdivision of a State may directly or indirectly establish under any authority or continue in effect restrictions with respect to the manufacture or introduction or delivery for introduction into interstate commerce of rinse-off cosmetics containing plastic microbeads (as defined in section 301(ddd) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a)) that are not identical to the restrictions under such section 301(ddd) that have begun to apply under subsection (b) [set out as a note above].”

For

of Federal Security Administrator to Secretary of Health, Education, and Welfare [now Health and Human Services], and of Food and Drug Administration in the Department of Agriculture to Federal Security Agency, see notes set out under section 321 of this title.